Education
About Us
Working with TipRanks
Follow Us
Metlife (MET)
NYSE:MET
MET Stock Chart & Stats
$76.38
$0.03(0.04%)
At close: 4:00 PM EST
$76.38
$0.03(0.04%)
Day’s Range― - ―
52-Week Range$65.21 - $87.39
Previous CloseN/A
Volume1.32M
Average Volume (3M)3.48M
Market Cap
$50.33B
Enterprise Value$50.20B
Total Cash (Recent Filing)$114.77B
Total Debt (Recent Filing)$19.83B
Price to Earnings (P/E)16.2
Beta0.94
Next Earnings
May 06, 2026EPS Estimate
2.2Next Dividend Ex-DateN/A
Dividend Yield2.78%
Share Statistics
EPS (TTM)2.49
Shares Outstanding658,891,660
10 Day Avg. Volume4,651,914
30 Day Avg. Volume3,479,143
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)2.06
Price to Sales (P/S)0.81
P/FCF Ratio3.73
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue0.71
Enterprise Value/Gross Profit2.94
Enterprise Value/Ebitda8.39
Forecast
1Y Price Target
$94.09Price Target Upside23.19% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)9.83
Revenue Forecast (FY)$78.71B
Bulls Say, Bears Say
Bulls Say
Cash Flow And ReturnsA strategic shift toward less capital-intensive businesses and improved free cash flow conversion should support expansion of return on equity and stronger cash generation.
Market PositionLeading positions in US group benefits and institutional retirement provide a platform to capture market share in higher-growth, higher-return product areas.
Segment RestructuringSeparating the asset management unit into its own segment could create valuation arbitrage by allowing investors to value higher-growth businesses independently.
Bears Say
Credit And Real Estate ExposureLow yields on newly issued corporate bonds combined with a relatively higher-risk commercial mortgage portfolio create potential downside if credit spreads widen or commercial real estate weakens.
Shareholder Return ExecutionShare repurchases falling short of forecasts reduces buyback support for the share price and limits the company’s ability to return capital to shareholders.
Valuation RiskRelative expensiveness versus many mid-cap peers raises the risk of multiple compression if growth or margin improvements fail to materialize.
Metlife News
MET FAQ
What was Metlife’s price range in the past 12 months?
Metlife lowest stock price was $65.21 and its highest was $87.39 in the past 12 months.
What is Metlife’s market cap?
Metlife’s market cap is $50.33B.
When is Metlife’s upcoming earnings report date?
Metlife’s upcoming earnings report date is May 06, 2026 which is in 85 days.
How were Metlife’s earnings last quarter?
Metlife released its earnings results on Feb 04, 2026. The company reported $2.49 earnings per share for the quarter, beating the consensus estimate of $2.336 by $0.154.
Is Metlife overvalued?
According to Wall Street analysts Metlife’s price is currently Undervalued.
Does Metlife pay dividends?
Metlife pays a Quarterly dividend of $0.568 which represents an annual dividend yield of 2.78%. See more information on Metlife dividends here
What is Metlife’s EPS estimate?
Metlife’s EPS estimate is 2.2.
How many shares outstanding does Metlife have?
Metlife has 658,891,660 shares outstanding.
What happened to Metlife’s price movement after its last earnings report?
Metlife reported an EPS of $2.49 in its last earnings report, beating expectations of $2.336. Following the earnings report the stock price went down -3.448%.
Which hedge fund is a major shareholder of Metlife?
Currently, no hedge funds are holding shares in MET
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Metlife Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$94.09 (23.19% Upside)
$94.09 (23.19% Upside)
Blogger Sentiment
Bullish
MET Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 596.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
News Sentiment
Very Bullish
Bullish news 92%
Bearish news 8%
Bearish news 8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.99%
12-Months-Change
Fundamentals
Return on Equity
12.10%
Trailing 12-Months
Asset Growth
9.99%
Trailing 12-Months
Company Description
Metlife
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
MET Company Deck
MET Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong operational momentum across multiple businesses, robust top-line growth, successful strategic actions (PineBridge, reinsurance, PRT origination) and achievement of key 2025 targets (adjusted EPS growth, ROE, expense efficiency, and free cash flow progress). Primary near-term concerns include a modest shortfall in variable investment income (and slightly lower-than-expected private equity/real estate returns), an anticipated 2026 drag from corporate & other, a temporary rise in the direct expense ratio due to the PineBridge acquisition, and some line-specific underwriting pressure (disability). Taken together, the positives — including record PRT origination, strong regional sales, AUM growth, capital returns, and adherence to strategic commitments — materially outweigh the headwinds described, supporting a constructive outlook.View all MET earnings summariesMET Revenue Breakdown
37.71% Group Benefits
24.86% RIS
16.33% Asia
12.26% MetLife Holdings
14.82% Other
MET Stock 12 Month Forecast
Average Price Target
$94.09
▲(23.19% Upside)
Technical Analysis
Ownership Overview
0.27% Insiders
26.09% Mutual Funds
0.12% Other Institutional Investors
52.41% Public Companies and Individual Investors